Patents Assigned to Wesleyan University
  • Patent number: 8551700
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: October 8, 2013
    Assignees: The Brigham and Women's Hospital, Inc., Wesleyan University
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Li-Li Hsiao, Raphael Bueno
  • Patent number: 7622260
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: November 24, 2009
    Assignees: The Brigham and Women's Hospital, Inc., Wesleyan University
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Raphael Bueno, Li-Li Hsiao
  • Publication number: 20090104617
    Abstract: The invention provides methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, such as cancer tissue samples. The invention also provides sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets of genes can be used to discriminate between normal and malignant tissues, and between classes of malignant tissues. Accordingly, diagnostic assays for classification of tumors, prediction of tumor outcome, selecting and monitoring treatment regimens and monitoring tumor progression/regression also are provided.
    Type: Application
    Filed: December 5, 2008
    Publication date: April 23, 2009
    Applicants: The Brigham And Women's Hospital, Inc., Wesleyan University
    Inventors: Gavin J. Gordon, Roderick V. Jensen, Steven R. Gullans, Li-Li Hsiao, Raphael Bueno
  • Patent number: 5155546
    Abstract: A method for quantitatively determining the total organic carbon and vitrinite reflectance of rocks and sediments utilizes the entire visible light spectrum. A sample is prepared and placed in a spectrophotometer. The spectrophotometer has a light source that produces the entire visible light spectrum. A monochromator passes narrow wavelength bands of the source light therethrough to illuminate the sample. The total diffuse reflectance spectrum is obtained from the sample using the spectrophotometer. The reflectance spectral data are processed by determining the first derivative and by comparing it to calibration data of known total organic carbon and vitrinite reflectance.
    Type: Grant
    Filed: June 3, 1991
    Date of Patent: October 13, 1992
    Assignee: Texas Wesleyan University, Inc.
    Inventors: William L. Balsam, Bobby C. Deaton